vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and OLAPLEX HOLDINGS, INC. (OLPX). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $105.1M, roughly 1.2× OLAPLEX HOLDINGS, INC.). NATURES SUNSHINE PRODUCTS INC runs the higher net margin — 3.3% vs -12.5%, a 15.8% gap on every dollar of revenue. On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs 4.3%). OLAPLEX HOLDINGS, INC. produced more free cash flow last quarter ($32.6M vs $7.6M). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs 3.1%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
Olaplex Holdings, Inc. is a specialty beauty company developing and selling patented bond-repair hair care products. It runs three core segments: professional salon distribution, direct-to-consumer sales, and third-party retail, serving customers across North America, Europe, and Asia-Pacific with products that repair and protect damaged hair.
NATR vs OLPX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $105.1M |
| Net Profit | $4.1M | $-13.1M |
| Gross Margin | 72.5% | 68.0% |
| Operating Margin | 4.3% | -4.3% |
| Net Margin | 3.3% | -12.5% |
| Revenue YoY | 4.7% | 4.3% |
| Net Profit YoY | 1379.4% | -48.9% |
| EPS (diluted) | $0.23 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $105.1M | ||
| Q3 25 | $128.3M | $114.6M | ||
| Q2 25 | $114.8M | $106.3M | ||
| Q1 25 | $113.2M | $97.0M | ||
| Q4 24 | $118.2M | $100.7M | ||
| Q3 24 | $114.6M | $119.1M | ||
| Q2 24 | $110.6M | $103.9M | ||
| Q1 24 | $111.0M | $98.9M |
| Q4 25 | $4.1M | $-13.1M | ||
| Q3 25 | $5.3M | $11.1M | ||
| Q2 25 | $5.3M | $-7.7M | ||
| Q1 25 | $4.7M | $465.0K | ||
| Q4 24 | $-321.0K | $-8.8M | ||
| Q3 24 | $4.3M | $14.8M | ||
| Q2 24 | $1.3M | $5.8M | ||
| Q1 24 | $2.3M | $7.7M |
| Q4 25 | 72.5% | 68.0% | ||
| Q3 25 | 73.3% | 69.1% | ||
| Q2 25 | 71.7% | 71.2% | ||
| Q1 25 | 72.1% | 69.5% | ||
| Q4 24 | 72.0% | 66.3% | ||
| Q3 24 | 71.3% | 68.6% | ||
| Q2 24 | 71.4% | 69.7% | ||
| Q1 24 | 71.2% | 72.1% |
| Q4 25 | 4.3% | -4.3% | ||
| Q3 25 | 7.0% | 3.7% | ||
| Q2 25 | 3.7% | -1.1% | ||
| Q1 25 | 5.4% | 8.7% | ||
| Q4 24 | 3.8% | 3.0% | ||
| Q3 24 | 4.6% | 23.5% | ||
| Q2 24 | 5.1% | 15.7% | ||
| Q1 24 | 4.2% | 19.8% |
| Q4 25 | 3.3% | -12.5% | ||
| Q3 25 | 4.2% | 9.7% | ||
| Q2 25 | 4.6% | -7.3% | ||
| Q1 25 | 4.2% | 0.5% | ||
| Q4 24 | -0.3% | -8.7% | ||
| Q3 24 | 3.8% | 12.4% | ||
| Q2 24 | 1.2% | 5.6% | ||
| Q1 24 | 2.1% | 7.8% |
| Q4 25 | $0.23 | $-0.02 | ||
| Q3 25 | $0.30 | $0.02 | ||
| Q2 25 | $0.28 | $-0.01 | ||
| Q1 25 | $0.25 | $0.00 | ||
| Q4 24 | $-0.02 | $-0.01 | ||
| Q3 24 | $0.23 | $0.02 | ||
| Q2 24 | $0.07 | $0.01 | ||
| Q1 24 | $0.12 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $318.7M |
| Total DebtLower is stronger | — | $352.3M |
| Stockholders' EquityBook value | $161.6M | $879.4M |
| Total Assets | $261.1M | $1.5B |
| Debt / EquityLower = less leverage | — | 0.40× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $318.7M | ||
| Q3 25 | $95.6M | $286.4M | ||
| Q2 25 | $81.3M | $289.3M | ||
| Q1 25 | $86.5M | $580.9M | ||
| Q4 24 | $84.7M | $586.0M | ||
| Q3 24 | $78.7M | $538.8M | ||
| Q2 24 | $68.7M | $507.9M | ||
| Q1 24 | $77.8M | $507.5M |
| Q4 25 | — | $352.3M | ||
| Q3 25 | — | $352.1M | ||
| Q2 25 | — | $351.9M | ||
| Q1 25 | — | $649.1M | ||
| Q4 24 | — | $650.5M | ||
| Q3 24 | — | $651.8M | ||
| Q2 24 | — | $653.1M | ||
| Q1 24 | $2.1M | $654.4M |
| Q4 25 | $161.6M | $879.4M | ||
| Q3 25 | $166.7M | $888.7M | ||
| Q2 25 | $163.7M | $874.2M | ||
| Q1 25 | $167.1M | $878.3M | ||
| Q4 24 | $161.0M | $874.4M | ||
| Q3 24 | $162.6M | $879.7M | ||
| Q2 24 | $156.4M | $863.3M | ||
| Q1 24 | $159.7M | $855.7M |
| Q4 25 | $261.1M | $1.5B | ||
| Q3 25 | $264.8M | $1.5B | ||
| Q2 25 | $254.9M | $1.5B | ||
| Q1 25 | $252.7M | $1.8B | ||
| Q4 24 | $240.9M | $1.8B | ||
| Q3 24 | $245.3M | $1.8B | ||
| Q2 24 | $235.8M | $1.8B | ||
| Q1 24 | $247.3M | $1.8B |
| Q4 25 | — | 0.40× | ||
| Q3 25 | — | 0.40× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.74× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.76× | ||
| Q1 24 | 0.01× | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $32.7M |
| Free Cash FlowOCF − Capex | $7.6M | $32.6M |
| FCF MarginFCF / Revenue | 6.1% | 31.0% |
| Capex IntensityCapex / Revenue | 1.9% | 0.1% |
| Cash ConversionOCF / Net Profit | 2.41× | — |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $58.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $32.7M | ||
| Q3 25 | $18.5M | $8.0M | ||
| Q2 25 | $4.3M | $20.9M | ||
| Q1 25 | $2.6M | $-2.9M | ||
| Q4 24 | $12.2M | $49.7M | ||
| Q3 24 | $9.6M | $33.5M | ||
| Q2 24 | $1.3M | $16.2M | ||
| Q1 24 | $2.2M | $43.7M |
| Q4 25 | $7.6M | $32.6M | ||
| Q3 25 | $16.8M | $7.9M | ||
| Q2 25 | $3.0M | $20.8M | ||
| Q1 25 | $1.5M | $-3.0M | ||
| Q4 24 | $10.0M | $49.2M | ||
| Q3 24 | $7.9M | $33.3M | ||
| Q2 24 | $-2.0M | $16.1M | ||
| Q1 24 | $-1.5M | $43.3M |
| Q4 25 | 6.1% | 31.0% | ||
| Q3 25 | 13.1% | 6.9% | ||
| Q2 25 | 2.6% | 19.6% | ||
| Q1 25 | 1.3% | -3.1% | ||
| Q4 24 | 8.5% | 48.9% | ||
| Q3 24 | 6.9% | 28.0% | ||
| Q2 24 | -1.9% | 15.5% | ||
| Q1 24 | -1.4% | 43.7% |
| Q4 25 | 1.9% | 0.1% | ||
| Q3 25 | 1.3% | 0.1% | ||
| Q2 25 | 1.2% | 0.1% | ||
| Q1 25 | 1.0% | 0.0% | ||
| Q4 24 | 1.9% | 0.4% | ||
| Q3 24 | 1.5% | 0.1% | ||
| Q2 24 | 3.0% | 0.1% | ||
| Q1 24 | 3.3% | 0.5% |
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | 0.72× | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | 0.55× | -6.27× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | 2.26× | ||
| Q2 24 | 0.97× | 2.81× | ||
| Q1 24 | 0.94× | 5.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
OLPX
| Sales Channel Directly To Consumer | $43.6M | 42% |
| Sales Channel Through Intermediary Professional | $36.8M | 35% |
| Sales Channel Through Intermediary Specialty Retail | $24.7M | 23% |
